Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at whether a digital support tool can help people with depression. Participants take part in a digital support tool and complete follow-up assessments.
This study is comparing ARTEMIS with Waitlist Control (WLC) for people with Stimulant Use, Human Immunodeficiency Virus, or Depression. Participants receive ARTEMIS or Waitlist Control (WLC) and complete study visits and assessments.
This study is comparing Walk-and-talk therapy with Waitlist control for people with depression or anxiety. Participants receive Walk-and-talk therapy or Waitlist control and complete study visits and assessments.
This study is looking at whether questionnaires and follow-up can help people with Depression in Adolescence or Anxiety. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at whether a digital support tool can help people with Mental Health Literacy or Depression, Anxiety. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether ReStoreD can help people with Stroke, Depression, Anxiety, Coping Skills, or Couples. Participants take part in ReStoreD and complete follow-up assessments.
This observational study is following people with Depression anxiety, Adjustment Disorders, Adjustment Disorder With Anxious Mood, or Adjustment Disorder With Depressed Mood to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at whether Sleep on Schedule can help people with depression or anxiety. Participants take part in Sleep on Schedule and complete follow-up assessments.
This study is looking at care and outcomes for people with Chronic Pain or Depression. Taking part may give some people access to Ketamine, but direct benefit is not guaranteed.
This observational study is following people with major depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is comparing Psilocybin and Psilocyn with placebo for people with depression. Participants receive Psilocybin and Psilocyn or placebo and complete study visits and assessments.
This study is comparing Low Dose Psilocybin with placebo for people with depression. Participants receive Low Dose Psilocybin or placebo and complete study visits and assessments.
This study is comparing Psilocybin with Control for people with Major Depression. Participants receive Psilocybin or Control and complete study visits and assessments.
This study is comparing Psilocybin (drug) with placebo for people with Treatment Resistant Depression. Participants receive Psilocybin (drug) or placebo and complete study visits and assessments.
This study is looking at whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy for people with Parkinson Disease or Depression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a digital support tool can help people with depression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is comparing Psilocybin with placebo for people with depression or Alcohol Use Disorder. Participants receive Psilocybin or placebo and complete study visits and assessments.
This study is comparing Psilocybin with placebo for people with depression. Participants receive Psilocybin or placebo and complete study visits and assessments.
This study is looking at also assess whether psilocybin may improve quality of life in those individuals for people with Depressive Symptoms, Depression, Alzheimer Disease, or Mild Cognitive Impairment. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at determine the safety and feasibility of performing psilocybin-assisted psychotherapy in patients hospitalized for treatment-resistant depression for people with Treatment Resistant Depression. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is comparing Psilocybin 25 mg with placebo for people with major depression. Participants receive Psilocybin 25 mg or placebo and complete study visits and assessments.
This study is looking at evaluate the efficacy of psilocybin on the symptom of anhedonia in individuals with treatment-resistant major depressive disorder for people with depression, Anhedonia, or Treatment Resistant Depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether questionnaires and follow-up can help people with Treatment Resistant Depression or Autism Spectrum Disorder. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a digital support tool can help people with Chronic Low-back Pain or Depression. Participants receive a study treatment and complete follow-up visits and assessments.